This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
News|Articles|November 13, 2008
ICH Leaders Meet
Author(s)Angie Drakulich
The Steering Committee and Expert Working Groups of the International Conference on Harmonization are meeting this week in Brussels to discuss current harmonization efforts.
Advertisement
Brussels, Belgium (Nov. 13)-The Steering Committee and Expert Working Groups of the International Conference on Harmonization are meeting this week in Brussels to discuss current harmonization efforts.
ICH Q8R Pharmaceutical Development is expected to be finalized. Q8R will provide more clarity on quality by design and specifically “design space.” In addition, the Implementation Working Group for ICH Q10 Pharmaceutical Quality System, which is in Step 5 of the harmonization process, is discussing next steps.
Also this week in Brussels, ICH is holding a meeting for the public to provide information on recent developments at ICH in the context of globalization and international cooperation. Pharmaceutical Technology will report on the outcome of these meetings in next week’s ePT.
In related news, the Clinical Data Interchange Standards Consortium (CDISC) is working to harmonize information technology standards for clinical research and electronic health records. CDISC met with the Health Information Technology Standards Panel on Monday to encourage a global solution.
Advertisement
Related to this article
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Advertisement
Advertisement